-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our 12-month target price by $10 to $110, valuing TROW shares at 11.3x our 2026 EPS estimate of $9.76 (lowered by $0.34) and at 11x our 2027 EPs estimate of $10.02 (cut by $0.23), versus their one-year average forward multiple of 10.6x and a peer average of 16x, which includes firms with wider margins and better organic growth prospects. TROW posted Q1 adjusted EPS of $2.52 versus $2.23 in the prior year, beating our $2.50 estimate and the $2.35 consensus estimate. However, results were overshadowed by continued structural headwinds. Net outflows of $13.7B were dominated by $22.6B in outflows from equity funds, reflecting the ongoing secular shift away from active equity strategies. AUM declined $65.9B to $1.7T due to outflows and $52.2B in market depreciation. Meanwhile, fee rate compression continued, with the rate falling to 38.4 bps from 40.0 bps in the prior year. Despite TROW's discounted valuation to peers, we believe the shares lack a near-term catalyst.